InvestorsHub Logo
Followers 35
Posts 2664
Boards Moderated 0
Alias Born 06/08/2014

Re: None

Wednesday, 02/16/2022 8:25:30 AM

Wednesday, February 16, 2022 8:25:30 AM

Post# of 424163
SVB Leerink analyst Roanna Ruiz maintains Amarin Corp with a Outperform and lowers the price target from $11 to $10.

Can't argue with the lower price target. I mean AMRN management is virtually nonexistent. Leerink has a healthcare conference literally going on today. Where is AMRN? Either they don't give a damn about the stock price and couldn't be bothered attending or they were not invited. Either of those scenarios is very concerning. Denner is really our only hope right now. Considering what KM has done so far, I have very low expectations for the earnings call. Hope I am wrong.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News